← Eichor
Study identifier: NCT06449937 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Local Liver Treatment for Multi-organ Colorectal Cancer Metastases

Condition: Metastatic Colorectal Carcinoma · Multi-organ Metastatic Colorectal Cancer · Metastatic Malignant Neoplasm in the Liver  ·  Sponsor: Anhui Provincial Hospital

PhaseNA
Planned participants130
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

The purpose of this study was to investigate the effect of only local radical treatment of liver metastases combined with systematic treatment in the treatment of patients with multiple organ metastases of colorectal cancer, whether it can benefit the prognosis and explore the risk factors related to the prognosis.

This description comes directly from the study's public registry record.

Talk to the study team

Ji-Zhou Wang, MD PhD  ·  +86 13836135864  ·  wangjoe@ustc.edu.cn

Always discuss trial participation with your own doctor first.

Locations (6)

The First People's Hospital of Chu ZhouChuzhou, Anhui, ChinaRecruiting
Fuyang Cancer HospitalFuyang, Anhui, ChinaRecruiting
Anhui province hospitalHefei, Anhui, ChinaRecruiting
Ma'anshan People's HospitalMa’anshan, Anhui, ChinaRecruiting
The First Affiliated Hospital of Wannan Medical CollegeWuhu, Anhui, ChinaRecruiting
The Second People's Hospital of WuhuWuhu, Anhui, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06449937